Synapse - Neil Shah

Results (83)

HER2 mutation and bladder cancer (BC): Prevalence and clinical outcomes

Meeting Abstract

Shah, N. J.; Aggen, D. H.; Zheng, J.; Niederhausern, A.; Alam, S. M.; Balar, O.; Bahadur, N.; Watson, A.; Regazzi, A. M.; Ratna, N.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Evolving metastatic renal cell carcinoma (mRCC) treatment landscape in the post vascular endothelial growth factor (VEGF) and immune checkpoint inhibitor (IO) setting

Meeting Abstract

Shah, N. J.; Bhattacharya, R.; Ning, N.; Shinde, R.; Schmier, J.; Tan, M. L. D.; Lemasters, T.; Sundaram, M.; Perini, R. F.; Motzer, R. J.
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Checkpoint inhibitor-related skin reactions in cancer patients are characterized by unique rash specific immune responses

Meeting Abstract

Goleva, E.; Lacouture, M.; Lyubchenko, T.; Gu, S.; Xiao, O.; Kraehenbuehl, L.; Berdyshev, E.; Ketosugbo, K.; Moy, A.; Rotemberg, V.; more...
Journal of Allergy and Clinical Immunology (2024)

Fulltext@MSK | Save

Real-world treatment patterns and clinical outcomes of metastatic renal cell carcinoma patients post immune-oncology (IO) and vascular endothelial growth factor (VEGF) receptor targeted therapies

Meeting Abstract

Shah, N.; Sura, S.; Shinde, R.; Wentworth, C.; Conkling, P.; Bupathi, M.; Perini, R.; Vickery, D.; Motzer, R.
The Oncologist (2024)

Fulltext@MSK | Save

A phase 1b, open-label, safety, tolerability, and efficacy study of HC-7366 in combination with belzutifan (WELIREG(TM)) in patients with advanced or metastatic renal cell carcinoma, NCT06234605

Meeting Abstract

McKay, R. R.; Garmezy, B.; Barata, P.; Ornstein, M.; Shah, N. J.; Hammers, H.; Hutson, T. E.; Chisamore, M.; Karim, D.; Mattson, P.; more...
The Oncologist (2024)

Fulltext@MSK | Save

Immune-related adverse event prediction and influential factor identification

Meeting Abstract

Zhang, Y.; Lev-Ari, S.; Shah, N. J.; Gupta, S.; Zaemes, J. P.; Alaoui, A.; McGarvey, P.; Atkins, M. B.
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Associations of dietary fructose with survival of patients (pts) with metastatic cancer of the urothelium (UC) and renal cell carcinoma (RCC) on immune checkpoint blockade (ICB)

Meeting Abstract

Badri, A.; Guercio, B. J.; Ratna, N.; Gavrilov, D.; Metzker, N.; Duzgol, C.; Teo, M. Y.; Regazzi, A. M.; Supplice, L.; Funt, S. A.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Clinical outcomes of sacituzumab govitecan (SG) after prior exposure to enfortumab vedotin (EV) in patients with metastatic urothelial carcinoma (mUC)